IJCS | Volume 33, Nº3, May / June 2020

207 1. Van der Linde D, Konings EEM, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ, Roos-Hesselink JW. Birth Prevalence of Congenital Heart Disease. J Am Coll Cardiol. 2011;58(21):2241-7. 2. Brasil. Ministério da Saúde. DATASUS.[acwsso em 2019 abr 15]. Disponível em: http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sinasc /cnv/ nvuf.def. 3. Bernier PL, Stefanescu A, Samoukovic G and Tchervenkov CI. The challenge of congenital heart disease worldwide: epidemiologic and demographic facts. Sem thorac cardiovasc surg. Pediatr Card SurgAnnu. 2010;13(1):26-34. 4. Brasil. Ministério da Saúde. Governo federal lança plano para ampliar atendimento de crianças com cardiopatia congênita. [Acesso em 2019 jan 11]. Disponível em :http://portalarquivos2.saude.gov.br/images/pdf/2017/ julho/11/21.06_Cardiopatia%20Congenita%20pediatrica.pdf 5. Pinto Jr VC, Rodrigues LC, Muniz CR. Reflexions about formulation of politics for attention to cardiovascular pediatrics in Brazil. Braz J Cardiovasc Surg. 2009;24(1):73-80. 6. Khairy P, Ionescu-Ittu R, MackieAS, Abrahamowicz M, Pilote L, Marelli AJ. Changing Mortality in Congenital Heart Disease. J Am Coll Cardiol. 2010; 56(14):1149-57. 7. Kemper AR. Lam WKK, Bocchini JA. The Success of State Newborn Screening Policies for Critical Congenital Heart Disease. JAMA. 2017; 318 (21): 2087-8. 8. Lopes SAVA, Guimarães ICB, Costa SFO,AcostaAX, Sandes KA, Mendes CMC. Mortalidade para Cardiopatias Congênitas e Fatores de Risco Associados emRecém-Nascidos. UmEstudo de Coorte.Arq Bras Cardiol. 2018; 111(5):666-73. 9. Jesus VS, Nascimento AM, Miranda RA, Lima JS, Tyll MAG, Veríssimo AOL. Fila de Espera para Tratamento de Pacientes com Cardiopatia Congênita: Retrato de um Centro de Referência Amazônico. Int J Cardiovasc Sci. 2018;31(4)374-82 10. Brasil. Ministério da Saúde. Portaria 1.727 de 11 de julho de 2017.Aprova o Plano Nacional de Assistência à Criança com Cardiopatia Congênita. [Acesso em 2019 jan 10]. Disponível em: http://bvsms.saude.gov.br/bvs/ saudelegis/gm/2017/prt1727_12_07_2017.html. 11. SalimTS, Soares GP, Klein CH, Oliveira GMM. Mortalidade por Doenças e Malformações doAparelho Circulatório emCrianças no Estado do Rio de Janeiro. Arq Bras Cardiol. 2016; 106(6):464-73 References Torbey & Grippa Challenge in the treatment of congenital heart disease Int J Cardiovasc Sci. 2020; 33(3):206-207 Editorial Recently, the Brazilian Ministry of Health, with the objective to expand the healthcare provided to children with heart diseases, approved a national action plan for children with congenital heart disease, the Plano Nacional de Assistência à Criança com Cardiopatia Congênita , aiming at establishing guidelines and actions that promote the access to diagnosis, treatment and rehabilitation of children and adolescents with congenital heart disease. 10 Investments not only in reducing waiting time for surgical treatment, but also in providing access to appropriate care, since diagnosis in the prenatal period until treatment, could have an impact on morbidity and mortality in this children with congenital heart disease, with direct effects on children mortality rates, mainly in early neonatal period. 11 Jesus et al., 9 also draw attention to the fact that most of heart diseases diagnosed in the study population were potentially treatable by cardiac catheterization (65.2%), such as persistent arterial duct, small interatrial communication, coarctation of the aorta and pulmonary valve stenosis. Therefore, to reduce the waiting time for cardiac surgery, the authors suggest the investment in percutaneous treatment, as it requires shorter hospitalization time, thereby promoting higher bed turnover rates in intensive care units and pediatric wards. Also, the authors discuss several strategies to improve health care for this group of patients, such as the development of specialized units and investments in diagnostic methods such as computed tomography angiography and magnetic resonance. 8,9 Therefore, improvements in health care for heart disease children must be a priority. To this end, a combined effort of public power, health professionals and society is needed. This is an open-access article distributed under the terms of the Creative Commons Attribution License